Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| AgBiome | 2021 | Series D | Undisclosed | Raleigh |
| Seismic Therapeutic | 2024 | Series B | Undisclosed | Watertown |
| Noetik | 2024 | Grant | Undisclosed | South San Francisco |
| Compass Therapeutics | 2025 | Post-IPO Equity | Undisclosed | Boston |
| Gossamer Bio | 2023 | Post-IPO Equity | Undisclosed | San Diego |
| Auron Therapeutics | 2025 | Venture - Series Unknown | Undisclosed | Newton |
| Cardurion Pharmaceuticals | 2024 | Series B | Undisclosed | Boston |
| OM1 | 2021 | Series D | Undisclosed | Boston |
| Engine Biosciences | 2026 | Venture - Series Unknown | $27.0M | Singapore |
| Leyden Labs | 2026 | Undisclosed | $35.2M | Amsterdam |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | AgBiome | Series D | Undisclosed | Raleigh, United States |
| 2 | Seismic Therapeutic | Series B | Undisclosed | Watertown, United States |
| 3 | Noetik | Grant | Undisclosed | South San Francisco, United States |
| 4 | Compass Therapeutics | Post-IPO Equity | Undisclosed | Boston, United States |
| 5 | Gossamer Bio | Post-IPO Equity | Undisclosed | San Diego, United States |
| 6 | Auron Therapeutics | Venture - Series Unknown | Undisclosed | Newton, United States |
| 7 | Cardurion Pharmaceuticals | Series B | Undisclosed | Boston, United States |
| 8 | OM1 | Series D | Undisclosed | Boston, United States |
| 9 | Engine Biosciences | Venture - Series Unknown | $27.0M | Singapore, Singapore |
| 10 | Leyden Labs | Undisclosed | $35.2M | Amsterdam, The Netherlands |
AgBiome discovers and develops innovative biological and trait products for crop protection.
Seismic Therapeutic is a biotechnology company developing machine-learning technology for immunology drug development.
Noetik is an AI-native biotechnology company that applies machine learning to large-scale human multimodal spatial omics datasets.
Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.
Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.
Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.
OM1 is a healthcare technology company that leverages real-world clinical data for medical research and personalized medicine.
Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.
Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.
Tavo Biotherapeutics is a biotech company that develops injection therapies for eye diseases.
Triveni Bio is a biotechnology company that develops antibody-based therapeutics for immunological and inflammatory diseases.
CubicPV is a solar manufacturing company that produces wafers and tandem modules.
Whisker Labs develops cutting-edge sensor technology to protect homes and communities from electrical fires and bad utility power.
Livara Health is a provider of non-operative, personalized treatment for musculoskeletal conditions.
ByHeart is a baby nutrition company with FDA-registered infant formula.
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Thirty Madison provides virtual healthcare and treatment for a portfolio of chronic conditions through its brands
QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.
Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.
Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.
Crossbow Therapeutics is a biotech company that develops targeted therapies to address cancer antigens.
Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.
Indomo is a clinical-stage firm that aims to improve access to quality healthcare through novel device-enabled treatments.
Polaris Partners has invested in 158 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Polaris Partners's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 30 different industry categories.
Among tracked funding rounds, Triveni Bio received $115.0M in a Series C round. Polaris Partners's total known invested capital is $5.6B.
Polaris Partners's average investment size is $53.2M across its portfolio of 158 companies.
Recent Polaris Partners portfolio additions include AgBiome, Seismic Therapeutic, Noetik, Compass Therapeutics, Gossamer Bio. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors